Replies to post #4002 on GTC Biotherapeutics (fka GTCB)

[rjmcanoe]

GTCB investment

The investment comunity will ask that GTC prove that they can be a profitable company. The investment community will ask that GTCB prove that they can generate 25 million in sales in europe on ATRN in a small indication"HD". So many times I have seen where events that on 1st thought looked positive actually caused the stock to go down. Look at amln they got approval for symln and a month later they got approval for byetta. in each case the price of the stock dropped until the company proved that they could sell byetta and generate profits and then finally the stock price went up. Unfortunately we may have to wait until sales of Atrn convince the investment community that this transgenic therapy is going to be profitable. The question now is to have a good launch and what is a good launch? Baring positive news from many of their other opportunities.
Bob